Rock Springs Capital Management LP Aprea Therapeutics, Inc. Transaction History

Rock Springs Capital Management LP

$2.94 Billion
Q3 2024

Shares

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2020 Feb 16, 2021	SELL	$4.92 - $30.67 $2.55 Million - $15.9 Million	-518,290 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$25.47 - $39.69 $465,846 - $725,930	18,290 Added 3.66%	518,290 $20.1 Million
Q1 2020 May 15, 2020	SELL	$31.65 - $45.3 $7.09 Million - $10.1 Million	-223,991 Reduced 30.94%	500,000 $17.4 Million
Q4 2019 Feb 14, 2020	BUY	$18.94 - $49.53 $13.7 Million - $35.9 Million	723,991 New	723,991 $33.2 Million

Others Institutions Holding APRE

# of Institutions

2

Shares Held

899

Call Options Held

0

Put Options Held

0

Nbc Securities, Inc. Birmingham, AL

899
Shares

$2,589
0.0% of portfolio
Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

About Aprea Therapeutics, Inc.

Ticker APRE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Description
Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel cancer therapeutics that target DNA damage response pathways. Its lead product candidate is ATRN-119, an oral ATR inhibitor that is in phase 1/2a clinical trial to treat patients with advanced solid tumors. The company's products...

More about APRE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Rock Springs Capital Management LP with notifications on news.